Shlomo Brill
Papers
1
Total Citations
7
H-Index
1
About
Shlomo Brill is a researcher whose work lies at the intersection of membrane biology and drug transport, with a particular focus on the mechanisms and inhibition of multidrug transporters. His most-cited study, "A liposomal method for evaluation of inhibitors of H+− coupled multidrug transporters" (2015, 7 citations), introduces a novel liposomal-based assay for assessing inhibitors of proton-coupled multidrug transporters. This contribution is significant because it provides a robust, cell-free platform for screening potential therapeutic agents that can overcome multidrug resistance—a major obstacle in treating infectious diseases and cancer. By enabling precise evaluation of transporter inhibition, Brill’s method has implications for drug discovery and the development of more effective treatments. While his citation count reflects a focused, emerging impact, his work demonstrates a commitment to addressing fundamental challenges in pharmacology and membrane transport, offering tools that can accelerate the identification of new inhibitors. Brill’s research is particularly valuable for students and researchers interested in the intersection of biophysics, drug design, and resistance mechanisms.
Research Focus
Key Achievements
Top Papers
- 1